MediPal Holdings Corporation

MEPDFOTCHealthcare● Active

$18.35

+$0.00(+0.00%)

Market Cap$3.8B

P/E Ratio—

52W High$19

52W Low$15.9

Avg Volume17

Open$18.35

Beta-0.04

Overview

MediPal Holdings Corporation (MEPDF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MEPDF · free cash flow · updated Jun 9, 2026

Core FCF metrics

MEPDF · FCF · TTM · margin & CAGR

Free cash flow was $40.18B for FY2026 (fiscal year ending 2026-03-31), down 16.5% year-over-year The FCF margin was 1.1%. Five-year CAGR stands at +16.4%.

FY2026 Free Cash Flow$40.18B▼ -16.5% YoY

Trailing 12M (TTM)$0trailing 4 quarters sum

FCF Margin1.1%$40.18B ÷ revenue

3-Year CAGR+147.8%FY2023 → FY2026

5-Year CAGR+16.4%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MEPDF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$46.85B(6.66B)$40.18B▼ 16.5%1.1%

FY2025$60.56B(12.43B)$48.13B▲ +13.4%1.3%

FY2024$61.84B(19.39B)$42.45B▲ +1506.7%1.2%

FY2023$16.15B(13.50B)$2.64B▼ 93.8%0.1%

FY2022$61.22B(18.88B)$42.34B▲ +125.4%1.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MEPDF · P/FCF · FCF yield · FCF per share

MediPal Holdings Corporation (MEPDF) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

MEPDF · cash flow statement · operating / investing / financing

For FY2026, MediPal Holdings Corporation generated $46.85B in operating cash flow and spent 6.66B in capital expenditures, yielding $40.18B in free cash flow.

Operating Activities

+$46.85B

Cash from core business operations

2026-03-31

Investing Activities

+$9.36B

CapEx, acquisitions & investments

2026-03-31

Financing Activities

−$29.58B

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF ($46.85B) − |CapEx| (6.66B) = FCF ($40.18B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MEPDF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

MediPal Holdings CorporationYOU

MEPDF

$40.18B-16.5%1.0%

100%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

40%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

22%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

MediPal Holdings Corporation (MEPDF) reported free cash flow of $40.18B for FY2026 (fiscal year ending 2026-03-31), down 16.5% year-over-year. The FCF margin was 1.1%.

Based on available data, MediPal Holdings Corporation has maintained positive free cash flow for at least 12 fiscal year(s). FCF peaked at $65.30B in FY2015. The 5-year CAGR stands at +16.4%.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MEPDF free cash flow · 8 questions

MediPal Holdings Corporation free cash flow was $40.18B for FY2026, down 16.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $0.

MEPDF free cash flowMEPDF FCFMEPDF FCF 2026MEPDF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · MediPal Holdings Corporation · MediPal Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026